Compass Therapeutics To Host Webcast On April 27 To Review Topline Secondary Endpoints From Phase 2/3 COMPANION-002 Clinical Study Assessing Tovecimig In Combination With Paclitaxel In Advanced Biliary Tract Cancer

Benzinga Newsdesk www.benzinga.com Neutral 86.0%

Neg 0% Neu 86% Pos 0%

Comments

No comments yet. Be the first!